StockData
Veru Inc. logo

Veru Inc. (VERU) stock

VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.14+0.06 (+2.88%)

Close on Nov 17, 2026Market cap $36.49MP/E –Yield –

Veru price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Veru's price to sales ratio was 4.8× on Jan 31, 2025, against 2.8× a year earlier. Over the last 5 years it ranged from 2.8× to 23.4×, with a median of 7.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20254.8×−0.8
2024Dec 31, 20245.6×+1.6
2023Dec 29, 20234.1×−6.7
2022Dec 30, 202210.8×+3.1
2021Dec 31, 20217.7×−6.5
2020Dec 31, 202014.2×+7.3
2019Dec 31, 20196.9×+2.0
2018Dec 31, 20184.9×+0.4
2017Dec 29, 20174.4×+3.2
2016Dec 30, 20161.2×−0.1
2015Dec 31, 20151.3×−3.3
2014Dec 31, 20144.6×−3.1
2013Dec 31, 20137.7×+1.9
2012Dec 31, 20125.9×−1.0
2011Oct 31, 20116.8×−0.2
2010Dec 31, 20107.0×+2.3
2009Dec 31, 20094.8×–

More Veru figures

See a number that looks wrong?